ArticleThe New England journal of medicine2020
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer.
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleThe New England journal of medicine2020
No numbers read from the abstract.